Cargando…
Teprotumumab-trbw as a Novel Monoclonal Antibody for Thyroid Eye Disease: A Literature Review
Thyroid eye disease (TED) can cause disfigurement and vision loss, most commonly in patients with Graves’ disease. These symptoms are related to orbital inflammation subsequently cause proptosis and limited eye movement. Traditionally, TED is treated with corticosteroids to decrease inflammation and...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511347/ https://www.ncbi.nlm.nih.gov/pubmed/37746376 http://dx.doi.org/10.7759/cureus.43878 |